Multiple drug-resistance in staphylococci, an analysis of all-nation computer-processed data.
In a previous communication from this Institute it was assessed that multiple drug resistance plays a decisive role in overall antibiotic resistance of staphylococci and that true data of the extent of multiresistance depend decisively on sufficient number of antibiotics toward which strains of a given species is tested. It was found, by analysis of more than 60 000 staphylococcal strains isolated by Public Health Laboratories in the Slovak Socialist Republic (S.S.R.) during the period of one year, that triple and quadruple resistance is the most prevalent one in staphylococci - not regarded, however, the penicillin resistance which is absolutely predominant. Present analysis also shows that resistances to streptomycin, tetracyclines, erythromycin and kanamycin (STEK type) are both most frequent and mutually selective, i.e. strains resistant to any of these drugs (and also to penicillin, i.e. PSTEK type) show resistance also to other antibiotics of this group. In contrast, chloramphenicol resistance seems not to be connected with resistance to these substances nor is resistance to newer specific anti-staphylococcal antibiotics, used only recently in this country, as is oxacillin, lincomycin and cefaloridin. Nevertheless, lincomycin seems to select a co-resistance as many lincomycin-resistant strains were resistant also to oxacillin but not vice versa. Increasing resistance of staphylococci in S.S.R. to kanamycin and particularly to erythromycin, and their frequent occurrence in multiresistance types is a warning feature which might lead to an increase of therapeutic crisis in staphylococcal infections.
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002509:Cephaloridine / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D001330:Electronic Data Processing; D004917:Erythromycin / Q000494:pharmacology; D007612:Kanamycin / Q000494:pharmacology; D008034:Lincomycin / Q000494:pharmacology; D010068:Oxacillin / Q000494:pharmacology; D010403:Penicillin Resistance; D013210:Staphylococcus / Q000187:drug effects*; D013307:Streptomycin / Q000494:pharmacology; D013752:Tetracycline / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D007612:Kanamycin; D004917:Erythromycin; D002701:Chloramphenicol; D008034:Lincomycin; D013752:Tetracycline; D002509:Cephaloridine; D010068:Oxacillin; D013307:Streptomycin